Skip to main content
SpringerLink
Log in

Beyond Nosology in Biological Psychiatry. 5-HT Disturbances in Mood, Aggression and Anxiety Disorders

  • Chapter
New Concepts in Depression

  • 19 Accesses

Abstract

5-HT disorders have been reported in depression, anxiety states, schizophrenia and alcoholism. The increasing number of psychiatric states in which serotonin (5-hydrotryptamine; 5-HT) apparently can be disturbed seems bewildering. The situation has been called chaotic, the findings themselves non-specific. Van Kämmen (1987) called 5-HT, ironically, a neurotransmitter of all seasons. We do not concur with either statement and in this chapter we explain why. First we discuss the available data; then we try to bring them into a conceptual framework.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams, D.B. (1979). Brain mechanisms for offence, defense and submission. Behav. Brain. Sci., 2, 201–41.

    Article  Google Scholar 

  • Asberg, M., Traskman, L., and Thoren, P. (1976). 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch. Gen. Psychiatr., 33, 1193–7.

    Google Scholar 

  • Asberg, M., Bertilsson, L., Martensson, B., Scalia-Thomba, G.-P., Thoren, P., and Traskman, L. (1984). CSF monoamine metabolites in melancholia. Acta. Psychiatr. Scand., 69, 201–19.

    Article  CAS  PubMed  Google Scholar 

  • Asberg, M., Nordstrom, L., and Traskman-Bendz, L. (1986). Biological factors in suicide. In Roy, A. (ed.), Suicide. Williams and Wilkins, Baltimore.

    Google Scholar 

  • Banki, C.M. (1977). Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women. J. Neural. Transm., 41, 135–43.

    Article  CAS  PubMed  Google Scholar 

  • Bioulac, B., Benezich, M., Renaud, B., Noel, B., and Roche, D. (1980). Serotonergic functions in 47, XYZ syndrome. Biol. Psychiatr., 15, 917.

    CAS  Google Scholar 

  • Bissette, G., Widerlov, E., Walleus, H., Karlsson, I., Eklund, K., Forsman, A., and Nemeroff, C.B. (1986). Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders. Arch. Gen. Psychiatr., 43, 1148–51.

    Article  CAS  PubMed  Google Scholar 

  • Brown, G.L., Ebert, M.E., Goyer, P.F., Jimerson, D.C., Klein, W.J., Bunney, W.E., and Goodwin, F.K. (1982). Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am. J. Psychiatr., 139, 741–6.

    Article  CAS  PubMed  Google Scholar 

  • Brown, G.L., Goodwin, F.K., Ballenger, J.C., Goyer, P.F., and Major, L.F. (1979). Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatr. Res., 1, 131–9.

    Article  CAS  Google Scholar 

  • Ceulemans, D.L.S., Hoppenbrouwers, M.L.J. A., Gelders, Y.G., and Reyntjens, A.J.M. (1985). The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatr., 18, 303–5.

    Article  CAS  Google Scholar 

  • Charney, D.S., and Heninger, G.R. (1986). Serotonergic function in panic disorders. Arch. Gen. Psychiatr, 43, 1059–65.

    Article  CAS  PubMed  Google Scholar 

  • Daruna, J.H. (1978). Patterns of monoamine activity and aggressive behavior. Neurosci. Biobehav. Rev., 2, 101–13.

    Article  CAS  Google Scholar 

  • Den Boer, J.A., Westenberg, H.G.M., Kamerbeek, W.D.J., Verhoeven, W.M.A., and Kahn R. S. (in press). Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharm.

    Google Scholar 

  • Evans, L., Kenardy, J., Schneider, P., and Hoey, H. (1986). Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr. Scand., 73, 49–53.

    Article  CAS  PubMed  Google Scholar 

  • Insel, T.R., Murphy, D.L., Cohen, R.M., Alterman, I., Kilts, C., and Linnoila, M. (1983). Obsessive compulsive disorder: A double blind trial of clomipramine and clorgyline. Arch. Gen. Psychiatr., 40, 605–12.

    Article  CAS  PubMed  Google Scholar 

  • Insel, T.R., Mueller, E.A., Alterman, I., Linnoila, M., and Murphy, D.L. (1985). Obsessive-compulsive disorder and serotonin: Is there a connection? Biol. Psychiatr., 20, 1174–88.

    Google Scholar 

  • Kahn, R.S., Westenberg, H.G.M., and Jolies, J. (1984). Zimelidine treatment of obsessive-compulsive disorder. Acta Psychiatr. Scand., 69, 259–61.

    Article  CAS  PubMed  Google Scholar 

  • Kahn, R.S., and Westenberg, H.G.M. (1985). 1-5-hydroxytryptophan in the treatment of anxiety disorders. J. Affect. Disord., 8, 197–200.

    Article  CAS  PubMed  Google Scholar 

  • Kahn, R.S., Westenberg, H.G.M., Verhoeven, W.M.A., Gispen-de Wied, C.C., and Kamerbeek, W.D.J. (in press). Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int. Clin. Psychopharm.

    Google Scholar 

  • Kahn, R.S., van Praag, H.M., Wetzler, S., Asnis, G.M., and Barr, J. (in press). Serotonin and anxiety revisited. Biol. Psychiatr.

    Google Scholar 

  • Kahn, R.S., Westzler, S., van Praag, H.M., and Asnis, G.M. (subm.). Indication for sero-tonergic supersensitivity in patients with panic disorder.

    Google Scholar 

  • Lemberger, L., Fuller, R.W., and Zerbe, R.L. (1985). Review. Use of specific serotonin uptake inhibitors as antidepressants. Clinical Neuropharmacol., 8, 299–317.

    Article  CAS  Google Scholar 

  • Lidberg, L., Asberg, M., and Sundquist-Stensman, U.B. (1984). 5-Hydroxyindoleacetic acid in attempted suicides who killed their children. Lancet, ii, 928.

    Google Scholar 

  • Lidberg, L., Tuck, J.R., Asberg, M., Scalia-Tomba, G.P., and Bertilsson, L. (1985). Homicide, suicide and CSF 5-HIAA. Acta Psychiatr. Scand., 71, 230–6.

    Article  CAS  PubMed  Google Scholar 

  • Linnoila, M., Virkhunen, M., Scheinin, M., Nuutila, A., Rimon, R., and Goodwin, F.K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sei., 33, 2609–14.

    Article  CAS  Google Scholar 

  • Linnoila, M. (1986). Monoamines and impulse control in humans. Paper read at the American College of Neuropsychopharmacology, Washington.

    Google Scholar 

  • Marks, I.M., Stern, R.S., Mawson, D., Cobb, J., and McDonald, R. (1980). Clomipramine and exposure for obsessive-compulsive rituals. Br. J. Psychiatr., 136, 1–25.

    Article  CAS  Google Scholar 

  • Montgomery, S.A. (1980). Clomipramine in obsessional neurosis: A placebo controlled trial. Pharm.Med., 1, 189–92.

    Google Scholar 

  • Morand, C., Young, S.N., and Ervin, F.R. (1983). Clinical response of aggressive schizophrenics to oral tryptophan. Biol. Psychiatr., 18, 575–8.

    CAS  Google Scholar 

  • Mueller, E.A., Sunderland, T., and Murphy, D.L. (1985). Neuroendocrine effects of m-CRP., a serotonin agonist, in humans. J. Clin. Endocrinol. Metab., 61, 1179–84.

    Article  CAS  PubMed  Google Scholar 

  • Mueller E. A., Murphy, D.L., and Sunderland, T. (1986). Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanisms of action in humans. Psychopharmacol., 89, 388–91.

    Article  CAS  Google Scholar 

  • Ninan P. T., van Kämmen, D.P., Scheinin, M., Linnoila, M., Bunney, W.E., and Goodwin, F.K. (1984). CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am. J. Psychiatr., 141, 566–9.

    Article  CAS  PubMed  Google Scholar 

  • Oliver, B., and Mos, J. (1986). Serenics and aggression. Stress and Med., 2, 197–209.

    Article  Google Scholar 

  • Plutchik, R., van Praag, H.M., and Conte, H. (in press). Suicide and violence risk in psychiatric patients. Arch. Gen. Psychiatr.

    Google Scholar 

  • Potter W.Z., Scheinin, M., Golden, R.N., Rudorfer, M.V., Cowdry, R.W., Calil, H.M., Ross, R.J., and Linnoila, M. (1985). Selective antidepressants and cerebrospinal fluid, Lack of specificity on norepinephrine and serotonin metabolites. Arch. Gen. Psychiatr., 42, 1171–7.

    Article  CAS  PubMed  Google Scholar 

  • Redmond, D.E., Katz, M.M., Maas, J.W., Swann, A., Casper, R., and Davis, J.M. (1986). Cerebrospinal fluid amine metabolites: Relationships with behavioural measurements in depressed, manic and healthy control subjects. Arch. Gen. Psychiatr., 43, 938–47.

    Article  PubMed  Google Scholar 

  • Rodgers, R.J., and Waters, A.J. (1985). Benzodiazepines and their antagonists: A pharma-coethological analysis with particular reference to effects on ‘aggression.’ Neurosci. Behav. Rev., 9, 21–35.

    Google Scholar 

  • Rydin, E., Schalling, D., and Asberg, M. (1982). Rorschach ratings in depressed and suicidal patients with low CSF 5-HIAA. Psychiatr. Res., 7, 229–43.

    Article  CAS  Google Scholar 

  • Shopsin, B., Gershon, S., and Friedman, E. (1976). PCPA reversal of tranylcypromine effects in depressed patients. Arch. Gen. Psychiatr., 33, 811–19.

    Article  CAS  PubMed  Google Scholar 

  • Stern, R.S., Marks, I.M., and Mawson, D. (1980). Clomipramine and exposure for compulsive rituals: Plasma levels, side effects and outcome. Br. J. Psychiatr., 136, 161–6.

    Article  CAS  Google Scholar 

  • Taylor, D.P., Eison, M.S., Riblet, L.A., and Vandermaelen, C.P. (1985). Pharmacological and clinical effects of buspirone. Pharmacol. Biochem. Behav., 23, 687–94.

    Article  CAS  PubMed  Google Scholar 

  • Thomson, J., Rankin, H., Ashcroft, J.W., Gates, C.M., McOneea, J.K., and Cummings, J.W. (1982). The treatment of depression in general practice: A comparison of 1-trypto-phan, amitriptyline and a combination of 1-tryptophan and amitriptyline with placebo. Psychiatr. Res., 12, 741–51.

    CAS  Google Scholar 

  • Thoren P., Asberg, M., Cronholm, B., Jornestedt, L., and Traskman, L. (1980). Clomipramine treatment of obsessive compulsive disorder: I. A controlled clinical trial. Arch. Gen. Psychiatr., 37, 1281–9.

    Article  CAS  PubMed  Google Scholar 

  • Traskman, L., Asberg, M., Bertillson, L., and Sjostrand, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatr., 38, 631–6.

    Article  CAS  PubMed  Google Scholar 

  • Traskman-Bendz, L., Asberg, M., Bertelsson, L., and Thoren, P. (1984). CSF monoamine metabolites of depressed patients during illness and recovery. Acta. Psychiatr. Scand., 69, 333–42.

    Article  CAS  PubMed  Google Scholar 

  • Valzelli, L. (1981). Psychobiology of Aggression and Violence. Raven, New York.

    Google Scholar 

  • van Kämmen, D.P. (1987). 5-HT., a neurotransmitter for all seasons? Biol Psychiatr., 22, 1–3.

    Google Scholar 

  • van Praag, H.M. (1977). Significance of biochemical parameters in the diagnosis, treatment and prevention of depressive disorders. Biol. Psychiatr., 12, 101–31.

    CAS  Google Scholar 

  • van Praag, H.M. (1982a). Neurotransmitters and CNS disease: depression. Lancet, ii, 1259–64.

    Google Scholar 

  • van Praag, H.M. (1982b). Depression, suicide and the metabolism of serotonin in the brain. J. Affect. Disor., 4, 275–90.

    Article  Google Scholar 

  • van Praag, H.M. (1983a). CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet, ii, 977–8.

    Google Scholar 

  • van Praag, H.M. (1983b). In search of the action mechanism of antidepressants, 5-HTP/ tyrosine mixtures in depression. Neuropharmacol., 22, 433–40.

    Article  Google Scholar 

  • van Praag, H.M. (1984a). Depression, suicide and serotonin metabolism in the brain. In Post, R.M., and Ballinger, J.C. (eds.), Neurobiology of Mood Disorders. Williams and Wilkins, Baltimore, 601–18.

    Google Scholar 

  • van Praag, H.M. (1984b). Studies in the mechanism of action of serotonin precursors in depression. Psychopharmacol Bull, 20, 599–602.

    PubMed  Google Scholar 

  • van Praag, H.M. (1985). Serotonin precursors with and without tyrosine in the treatment of depression. In Shadgrass, C., Josias, W., Bridger, K., Weiss, D., Stoff, D., and Simpson, J. (eds.), Proc. IV World Congr. of Biological Psychiatry. Elsevier, New York, 1986, 77–99.

    Google Scholar 

  • van Praag, H.M. (1986a). Biological suicide research. Outcome and limitations. Biol. Psychiatr., 21, 1305–23.

    Article  Google Scholar 

  • van Praag, H.M. (1986b). (Auto) aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacol. Bull, 2, 669–73.

    Google Scholar 

  • van Praag, H.M., and Leijnze, B. (1965). Neubewertung des sydroms. Skizze einer funktion-ellen pathologie. Psychiatr. Neurol. Neurochir., 68, 50–66.

    Google Scholar 

  • van Praag, H.M., Uleman, A.M., and Spitz, J.C. (1965). The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr. Neurol. Neurochir., 68, 329–46.

    PubMed  Google Scholar 

  • van Praag, H.M., Korf, J., and Puite, J. (1970). 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature, 225, 1259–60.

    Article  PubMed  Google Scholar 

  • van Praag, H.M., and Korf, J. (1971a). Retarded depression and the dopamine metabolism. Psychopharmacol, 19, 199–203.

    Article  Google Scholar 

  • van Praag, H.M., and Korf, J. (1971b). Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacol, 19, 148–52.

    Google Scholar 

  • van Praag, H.M., Korf, J., Lakke, J.P.W.F., and Schut, T. (1975). Dopamine metabolism in depression, psychoses and Parkinson’s disease: The problem of the specificity of biological variables in behaviour disorders. Psychol. Med., 5, 138–46.

    Article  CAS  PubMed  Google Scholar 

  • van Praag, H.M., and de Haan, S. (1979). Central serotonin metabolism and frequency of depression. Psychiatr. Res., 1, 219–24.

    Article  Google Scholar 

  • van Praag, H.M., and Lemus, C. (1986). Monoamine precursors in the treatment of psychiatric disorders. In Wurtman, J.J., and Wurtman, R.J. (eds.). Nutrition and the Brain. Raven, New York.

    Google Scholar 

  • van Praag, H.M., and Plutchik, R. (subm.). Increased suicidality in depression. Group or sub-group characteristic.

    Google Scholar 

  • van Praag, H.M., Lemus, C., and Kahn, R. (1987a). Hormonal probes of central serotonergic activity. Do they really exist? Biol Psychiatr., 22, 86–98.

    Google Scholar 

  • van Praag, H.M., Plutchik, R., and Korn, M. (in prep.). Relatedness of seriousness of suicide intent and seriousness of suicide attempt.

    Google Scholar 

  • van Praag, H.M., Kahn, R., Asnis, G.M., Lemus, C.Z., and Brown, S. (1987b). Therapeutic indications for serotonin-potentiating compounds: A hypothesis. Biol. Psychiatr., 22, 205–12.

    Article  Google Scholar 

  • Woods, S.W. (1986). Drug and phobic exposure induced anxiety states. American Psychiatric Association, 139th Annual Meeting, Washington DC.

    Google Scholar 

  • Wurtman, R.J. (1982). Nutrients that modify brain functions. Sei Am., 246, 42–51.

    Google Scholar 

  • Yaryuria-Tobias, J.S., and Bhagavan, H.N. (1977). L-Tryptophan in obsessive compulsive disorders. Am. J. Psychiatr., 134, 1298–9.

    Article  Google Scholar 

  • Young, S.N., Smith, S.E., Pihl, R.O., and Ervin, F.R. (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacol., 87, 173–7.

    Article  CAS  Google Scholar 

  • Zohar, J., and Insel, T.R. (in press). Obsessive compulsive disorder; psychobiological approaches to diagnosis, treatment and psychophysiology. Biol. Psychiatr.

    Google Scholar 

Download references

Authors
  1. H. M. van Praag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. S. Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. Asnis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Wetzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. L. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Bleich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. L. Korn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre de Recherche Pierre Fabre, 17 Avenue Jean Moulin, 81100, Castres, France

    M. Briley

  2. Unité de Pharmacologie Neuroimmunoendocrinienne, UA CNRS 1113, Institut Pasteur, 75015, Paris, France

    G. Fillion

Copyright information

© 1988 The Editors and the Contributors

About this chapter

Cite this chapter

van Praag, H.M. et al. (1988). Beyond Nosology in Biological Psychiatry. 5-HT Disturbances in Mood, Aggression and Anxiety Disorders. In: Briley, M., Fillion, G. (eds) New Concepts in Depression. Palgrave, London. https://doi.org/10.1007/978-1-349-09506-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-09506-3_8

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-09508-7

  • Online ISBN: 978-1-349-09506-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation